Vivacelle Bio

Vivacelle Bio is a life sciences company developing life-saving cardiovascular support fluids (VBI-S and VBI-1) using patented phospholipid nanoparticle technology. These fluids treat hypovolemia caused by sepsis, septic shock, or blood loss, offering a superior alternative to traditional methods. The company is focused on making these products readily available and affordable, particularly in Sub-Saharan Africa.

Buy Funded Startups lists

Funding Round: Series B

Funding Amount: $20M

Date: 22-Feb-2024

Investors: 2Flo Ventures

Markets: Life Sciences, Biomedicine, Healthtech, Biotechnology, Clinical Trials, Health Care

HQ: Chicago, Illinois, United States

Founded: 2013

Website: https://www.vivacellebio.com/

LinkedIn: https://www.linkedin.com/company/vivacelle-bio

Twitter:

Instagram: